Moreover, in colon carcinoma and sarcoma cells, treatment with HDAC inhibitor Entinostat, a class I HDAC1 and HDAC3 inhibitor, led to increase in expression of NKG2D ligand MICA and MICB, enhancing cytotoxicity of NK cells against tumor cells (25). This evidence concerns the gene HDAC1 and neoplasm.